Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines

Sanaria Inc. has developed methods to manufacture, purify and cryopreserve aseptic Plasmodium falciparum (Pf) sporozoites (SPZ), and is using this platform technology to develop an injectable PfSPZ-based vaccine that provides high-grade, durable protection against infection with Pf malaria. Several...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vaccine
Päätekijät: Richie, Thomas L., Billingsley, Peter F., Sim, B. Kim Lee, James, Eric R., Chakravarty, Sumana, Epstein, Judith E., Lyke, Kirsten E., Mordmüller, Benjamin, Alonso, Pedro, Duffy, Patrick E., Doumbo, Ogobara K., Sauerwein, Robert W., Tanner, Marcel, Abdulla, Salim, Kremsner, Peter G., Seder, Robert A., Hoffman, Stephen L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5077156/
https://ncbi.nlm.nih.gov/pubmed/26469720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.09.096
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia